SRTS Earnings & Financial Statements
Sensus Healthcare, Inc.
$2.86
-$0.03(-1.04%)
42
Overall
60
Value
10
Tech
57
Quality
Market Cap
$47.08M
Volume
10.39K
52W Range
$2.66 - $5.49
Target Price
$5.38
SRTS earnings and financial statements: Sensus Healthcare, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SRTS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $27.48M | $41.81M | $24.41M | $44.53M | $27.04M |
| Cost of revenue | $15.62M | $17.38M | $10.35M | $14.90M | $10.05M |
| Operating income | -$10.31M | $8.09M | -$382.0K | $14.83M | $4.12M |
| EBITDA | -$9.68M | $8.52M | $79.0K | $15.34M | $4.84M |
| Net income | -$7.72M | $6.65M | $485.0K | $24.24M | $4.12M |
| EPS (diluted) | $-0.47 | $0.41 | $0.03 | $1.46 | $0.25 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $53.04M | $62.16M | $53.71M | $56.73M | $32.24M |
| Total liabilities | $4.94M | $6.34M | $4.87M | $8.67M | $6.22M |
| Shareholders’ equity | $48.10M | $55.83M | $48.84M | $48.07M | $26.02M |
| Cash and equivalents | $22.08M | $22.06M | $23.15M | $25.52M | $14.52M |
| Long-term debt | $209.0K | $398.0K | $596.0K | $830.0K | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $528.0K | -$831.0K | -$2.15M | -$1.41M | -$286.0K |
| Capital expenditure | -$196.0K | -$276.0K | -$229.0K | -$159.0K | -$128.0K |
| Free cash flow | $332.0K | -$1.11M | -$2.37M | -$1.57M | -$414.0K |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRTS | $2.86 | -1.0% | 10.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |